Results for
IPKat
Beyond black and white: the EPO’s new rules for colour drawings
Reviewed by
Simone Lorenzi
on
Thursday, November 27, 2025
Rating:
5
Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23)
Reviewed by
Dr Rose Hughes
on
Tuesday, November 18, 2025
Rating:
5
Never Too Late: If you missed the IPKat last week!
Reviewed by
Wissam Bentazar
on
Saturday, October 18, 2025
Rating:
5
The reproducibility challenge for advanced therapies (T 0827/23)
Reviewed by
Dr Rose Hughes
on
Monday, August 04, 2025
Rating:
5
First UPC decision to tackle infringement and validity of second medical claims (Sanofi v Amgen, UPC_CFI_505/2024)
Reviewed by
Dr Rose Hughes
on
Monday, May 19, 2025
Rating:
5
Fordham 32 (Report 1): Patents in Pharma
Reviewed by
Annsley Merelle Ward
on
Thursday, April 24, 2025
Rating:
5
Beware of boilerplate: Practical lessons for patent drafting from G1/24 (Claim interpretation)
Reviewed by
Dr Rose Hughes
on
Friday, April 11, 2025
Rating:
5
[Guest post] Book review: ‘Developments and Directions in Intellectual Property Law: 20 Years of the IPKat’
Reviewed by
Merpel McKitten
on
Monday, August 07, 2023
Rating:
5
Farewell
Reviewed by
Neil Wilkof
on
Tuesday, June 27, 2023
Rating:
5
Never Too Late: If you missed the IPKat last week!
Reviewed by
Chiara Gallo
on
Wednesday, June 14, 2023
Rating:
5
The IPKat’s 20th Birthday Conference Reports – Part 4
Reviewed by
Henry P Yang
on
Sunday, June 11, 2023
Rating:
5
The IPKat’s 20th Birthday Conference Reports – Part 3
Reviewed by
Anna Maria Stein
on
Saturday, June 10, 2023
Rating:
5
The IPKat’s 20th Birthday Conference Reports – Part 2
Reviewed by
Anastasiia Kyrylenko
on
Friday, June 09, 2023
Rating:
5